Australia markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.30+0.72 (+2.61%)
At close: 04:00PM EDT
28.35 0.00 (0.00%)
After hours: 05:29PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
18,943
0
Operating expenses
Research development
148,156
148,156
91,948
57,751
43,211
Selling general and administrative
42,493
42,493
40,189
29,146
17,124
Total operating expenses
190,649
190,649
132,137
86,897
60,335
Operating income or loss
-190,649
-190,649
-132,137
-67,954
-60,335
Total other income/expenses net
-201
-201
276,842
-8
-11
Income before tax
-169,223
-169,223
151,316
-67,485
-59,458
Income tax expense
-14,122
-14,122
42,121
0
-
Income from continuing operations
-155,101
-155,101
109,195
-67,485
-59,458
Net income
-153,162
-153,162
111,214
-65,570
-51,799
Net income available to common shareholders
-153,162
-153,162
111,214
-65,570
-51,799
Basic EPS
-3.76
-
2.46
-1.52
-1.37
Diluted EPS
-3.76
-
2.38
-1.52
-1.37
Basic average shares
42,287
-
45,164
43,077
41,398
Diluted average shares
42,553
-
46,640
43,077
41,398